NFKB1 and central nervous system cancer: In summary, these findings indicate that olanzapine treatment inhibits NF‐κB activity by preventing the transfer of the p65 subunit from the cellular cytoplasm into the nucleus, and this inhibition may be related to autophagy induction in glioma cells.